Unknown

Dataset Information

Active surveillance versus treatment in low-risk DCIS: Women's preferences in the LORD-trial.


ABSTRACT:

Background

Ductal carcinoma in situ (DCIS) can progress to invasive breast cancer (IBC), but most DCIS lesions remain indolent. However, guidelines recommend surgery, often supplemented by radiotherapy. This implies overtreatment of indolent DCIS. The non-randomised patient preference LORD-trial tests whether active surveillance (AS) for low-risk DCIS is safe, by giving women with low-risk DCIS a choice between AS and conventional treatment (CT). Here, we aim to describe how participants are distributed among both trial arms, identify their motives for their preference, and assess factors associated with their choice.

Methods

Data were extracted from baseline questionnaires. Descriptive statistics were used to assess the distribution and characteristics of participants; them

SUBMITTER: Schmitz RSJM 

PROVIDER: S-EPMC10632767 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature